CASI
CASI Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for CASI Pharmaceuticals, Inc. (CASI), newest first, with AI summaries and stories.
- Ticker
- CASI
- CIK
- 1962738
- Latest filing
- Sep 4
Filings
6-KCASI Pharmaceuticals, Inc.CASIFLIVE 6-KCASI Pharmaceuticals, Inc.CASILIVE 6-KCASI Pharmaceuticals, Inc.CASIFLIVE 6-KCASI Pharmaceuticals, Inc.CASIFLIVE 6-KCASI Pharmaceuticals, Inc.CASILIVE 25-NSECASI Pharmaceuticals, Inc.CASIFLIVE Nasdaq Stock Market LLC, filed by
6-KCASI Pharmaceuticals, Inc.CASIFLIVE SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIFLIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
20-FCASI Pharmaceuticals, Inc.CASIFLIVE DCASI Pharmaceuticals, Inc.CASIFLIVE 3CASI Pharmaceuticals, Inc.CASIFLIVE Thomas Folinsbee, new insider at CASIF
Thomas Folinsbee, reporting
NT 20-FCASI Pharmaceuticals, Inc.CASIFLIVE 3CASI Pharmaceuticals, Inc.CASIFLIVE Xuebo Zeng, new insider at CASIF
Xuebo Zeng, reporting
6-KCASI Pharmaceuticals, Inc.CASIFLIVE 6-KCASI Pharmaceuticals, Inc.CASIFLIVE 3CASI Pharmaceuticals, Inc.CASIFLIVE Wei R Gao, new insider at CASIF
Wei R Gao, reporting
6-KCASI Pharmaceuticals, Inc.CASIFLIVE 3CASI Pharmaceuticals, Inc.CASIFLIVE Kun Qian, new insider at CASIF
Kun Qian, reporting
3CASI Pharmaceuticals, Inc.CASIFLIVE Hai Huang, new insider at CASIF
Hai Huang, reporting
3CASI Pharmaceuticals, Inc.CASIFLIVE 2 insider filings
Chunhua Wang, new insider at CASIF
Show all 2
- 3New insider at CASIF
- 3New insider at CASIF
Chunhua Wang, reporting
3CASI Pharmaceuticals, Inc.CASIFLIVE Barbara Helene Hannelore Krebs-Pohl, new insider at CASIF
Barbara Helene Hannelore Krebs-Pohl, reporting
3CASI Pharmaceuticals, Inc.CASIFLIVE Alex Wu, reporting
SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIFLIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
3CASI Pharmaceuticals, Inc.CASIFLIVE Wei-Wu He, new insider at CASIF
Wei-Wu He, reporting
3CASI Pharmaceuticals, Inc.CASIFLIVE James Huang, new insider at CASIF
James Huang, reporting
6-KCASI Pharmaceuticals, Inc.CASIFLIVE DCASI Pharmaceuticals, Inc.CASILIVE 6-KCASI Pharmaceuticals, Inc.CASILIVE 6-KCASI Pharmaceuticals, Inc.CASILIVE 6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13G/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)
Venrock Healthcare Capital Partners III, L.P., filed by
SCHEDULE 13G/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Foresite Capital Fund VI LP (amended)
Foresite Capital Fund VI LP, filed by
6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
DCASI Pharmaceuticals, Inc.CASILIVE 2 Form D filings
Private placement notice
Show all 2
- DPrivate placement notice
- DPrivate placement notice
6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Chi Sing Ho (amended)
Chi Sing Ho, filed by
SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by SPARKLE BYTE LTD (amended)
SPARKLE BYTE LTD, filed by
6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Wei-Wu He (amended)
Wei-Wu He, filed by
SCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Panacea Innovation Ltd (amended)
Panacea Innovation Ltd, filed by
6-KCASI Pharmaceuticals, Inc.CASILIVE SCHEDULE 13GCASI Pharmaceuticals, Inc.CASILIVE Ownership stake disclosure by Zhenfeng M Chen
Zhenfeng M Chen, filed by
6-KCASI Pharmaceuticals, Inc.CASILIVE CASI Pharmaceuticals, Inc. filed 6-K
- Form Type: 6-K
- Filing Date: 2025-11-19
6-KCASI Pharmaceuticals, Inc.CASILIVE